Outcome Following Percutaneous Transluminal Coronary Angioplasty Performed Before 1990

Détails

ID Serval
serval:BIB_C409BE38A75B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Outcome Following Percutaneous Transluminal Coronary Angioplasty Performed Before 1990
Périodique
Journal of Interventional Cardiology
Auteur⸱e⸱s
Mpyisi Samuel F., Santos-Eggimann Brigitte, Lubsen Jacobus, Eeckhout Eric, Goy Jean-Jacques, Kappenberger Lukas
ISSN
0896-4327 (Print)
1540-8183 (Electronic)
Statut éditorial
Publié
Date de publication
2002
Peer-reviewed
Oui
Volume
15
Numéro
5
Pages
355-361
Langue
anglais
Résumé
The goal of this follow-up study was to assess the long-term survival of all patients having undergone a first PTCA between 1981 and 1990 and to relate the outcome to the baseline clinical and angiographic state. Although PTCA has become a widely accepted therapeutic choice for revascularization, the authors lacked information on long-term outcome. Data was collected by questionnaire, the end points being a second PTCA, MI, CABG, death or any of these events. The survival curves were constructed using the Kaplan-Meier method. Multivariate analysis was performed by a Cox proportional hazards model. Complete follow-up data were collected for 1,071 patients for a mean period of 7.4 years (SEM +/- 1.98 months) with a range of 0 to 14 years. Mean age was 57 years. PTCA was successful in 85% of patients. In-hospital event rates were death 1.3%, MI 4.4%, and emergency CABG 2.9%. Overall survival at 14 years was 69% (SEM +/- 9.6%) and event-free survival was 47% (SEM +/- 5.8%). MI rate was 11%, CABG 15%, and 20% of patients underwent repeat PTCA. Presence of cardiovascular risk factors, poor left ventricular ejection fraction, and prior CABG were significantly associated with poorer event-free survival. The short-term observations are consistent with results reported by the other follow-up studies. In addition, the study found a total survival rate 14 years after a first PTCA of 69% and 47% of the cohort remained event free.
Mots-clé
Research Support, Non-U.S. Gov't , Angioplasty, Balloon, Coronary* , Disease-Free Survival , Female , Follow-Up Studies , Humans , Male , Middle Aged , Multivariate Analysis , Outcome Assessment (Health Care)* , Surveys and Questionnaires
Pubmed
Création de la notice
11/10/2016 16:10
Dernière modification de la notice
20/08/2019 16:39
Données d'usage